Schizophrenia Trials in Kazanlak, Bulgaria
Conditions / Schizophrenia / Kazanlak, Bulgaria
Schizophrenia is a medical condition with active clinical research programs worldwide.
26 total trials for this combination
Showing top 10 of 26 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01235559 | A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305) | COMPLETED | PHASE3 |
| NCT01192880 | A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia | COMPLETED | PHASE3 |
| NCT01515423 | Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia | COMPLETED | PHASE3 |
| NCT01903837 | A Study of ALKS 3831 in Adults With Schizophrenia | COMPLETED | PHASE2 |
| NCT02717195 | Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia | COMPLETED | PHASE3 |
| NCT03503318 | Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia | COMPLETED | PHASE3 |
| NCT03893825 | A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia | COMPLETED | PHASE3 |
| NCT02161718 | A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder | COMPLETED | PHASE2 |
| NCT05145413 | A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia | COMPLETED | PHASE3 |
| NCT05304767 | An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia | RECRUITING | PHASE3 |